| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Teresa Biermann, Nikolaos Stilianakis, Stefan Bleich, Norbert Thürauf, Johannes Kornhuber, Udo Reulbac. The hypothesis of an impact of ozone on the occurrence of completed and attempted suicides. Medical hypotheses. vol 72. issue 3. 2009-04-28. PMID:19027246. |
biologically, ozone is able to influence the immune system, is a strong trigeminal irritant and might influence neurotransmitter systems such as serotonin, which are known to vary with season and play a major role in impulsivity, aggression, depression and thereby suicidality. |
2009-04-28 |
2023-08-12 |
human |
| Mario Alexander Penzo, José Luis Peñ. Endocannabinoid-mediated long-term depression in the avian midbrain expressed presynaptically and postsynaptically. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 29. issue 13. 2009-04-23. PMID:19339608. |
the presynaptic mechanism consists of a decrease in neurotransmitter release, whereas a depression of nmdar-mediated current takes place on the postsynaptic side. |
2009-04-23 |
2023-08-12 |
chicken |
| Bianca Topic, Melly S Oitzl, Onno C Meijer, Joseph P Huston, Maria A de Souza Silv. Differential susceptibility to extinction-induced despair and age-dependent alterations in the hypothalamic-pituitary-adrenal axis and neurochemical parameters. Neuropsychobiology. vol 58. issue 3-4. 2009-04-16. PMID:19088491. |
these results show that neurobiological underpinnings of depression in the aged differ from those of adults, and underline the importance of investigating age-related alterations in hpa axis dynamics in conjunction with neurotransmitter systems to advance our knowledge about neuronal mechanisms of late-life and/or late-onset depression. |
2009-04-16 |
2023-08-12 |
human |
| E Engin, J Stellbrink, D Treit, C T Dickso. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience. vol 157. issue 3. 2009-04-14. PMID:18940236. |
however, despite its extensive expression in limbic areas, and its co-localization with gaba, a neurotransmitter previously implicated in emotion, the effects of sst on anxiety and depression have not been investigated. |
2009-04-14 |
2023-08-12 |
rat |
| Peter L Tenor. Psychotherapeutic benefits of opioid agonist therapy. Journal of addictive diseases. vol 27. issue 3. 2008-12-03. PMID:18956529. |
the most recent neurotransmitter theories on the origin of depression and anxiety will be reviewed, including current information on the role of serotonin, n-methyl d-aspartate, glutamate, cortisol, catecholamine, and dopamine in psychiatric disorders. |
2008-12-03 |
2023-08-12 |
Not clear |
| András Sümeg. [Domino principle--monoamines in bottom-view]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. vol 10. issue 3. 2008-12-03. PMID:18956617. |
much of the past 10-15 years of research in the biology of mood disorders has led to considerable evidence in depression implicating multiple system pathology, including abnormalities of monoamine as well as other neurotransmitter systems. |
2008-12-03 |
2023-08-12 |
Not clear |
| Alan L Mille. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Alternative medicine review : a journal of clinical therapeutic. vol 13. issue 3. 2008-12-01. PMID:18950248. |
the methylation, neurotransmitter, and antioxidant connections between folate and depression. |
2008-12-01 |
2023-08-12 |
Not clear |
| Alan L Mille. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Alternative medicine review : a journal of clinical therapeutic. vol 13. issue 3. 2008-12-01. PMID:18950248. |
without the participation of 5-mthf in this process, same and neurotransmitter levels decrease in the cerebrospinal fluid, contributing to the disease process of depression. |
2008-12-01 |
2023-08-12 |
Not clear |
| W Pitchot, G Scantamburlo, M Anssea. [Dopamine and depression: the forgotten neurotransmitter]. Revue medicale de Liege. vol 63. issue 5-6. 2008-11-14. PMID:18669208. |
[dopamine and depression: the forgotten neurotransmitter]. |
2008-11-14 |
2023-08-12 |
Not clear |
| Sanjay J Mathew, Husseini K Manji, Dennis S Charne. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 9. 2008-10-08. PMID:18172433. |
agents interacting with non-catecholamine neurotransmitter systems with particular promise for unipolar and bipolar depression include excitatory amino acid neurotransmitter modulators (eg, riluzole, n-methyl-d-aspartate antagonists, and ampa receptor potentiators) and neuropeptide antagonists (targeting corticotropin releasing factor-1 and neurokinin receptors). |
2008-10-08 |
2023-08-12 |
Not clear |
| Xiao-Jie Cao, Matthew J McGinley, Donata Oerte. Connections and synaptic function in the posteroventral cochlear nucleus of deaf jerker mice. The Journal of comparative neurology. vol 510. issue 3. 2008-09-24. PMID:18634002. |
in je/je animals the frequency of spontaneous mepscs was elevated, and synaptic depression in responses to trains of shocks delivered at between 100 and 333 hz was greater than in wild-type mice, indicating that the probability of neurotransmitter release was increased. |
2008-09-24 |
2023-08-12 |
mouse |
| D W Maas, R G J Westendorp, R C van der Mas. [Immune activation and depression in the elderly]. Nederlands tijdschrift voor geneeskunde. vol 152. issue 25. 2008-08-05. PMID:18624003. |
cytokines affect the hypothalamus-pituitary-adrenal axis and cerebral neurotransmitter systems, both of which are thought to be involved in depression. |
2008-08-05 |
2023-08-12 |
Not clear |
| Hymie Anisman, Zul Merali, Shawn Hayle. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Progress in neurobiology. vol 85. issue 1. 2008-07-23. PMID:18346832. |
neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. |
2008-07-23 |
2023-08-12 |
Not clear |
| David J Nut. Relationship of neurotransmitters to the symptoms of major depressive disorder. The Journal of clinical psychiatry. vol 69 Suppl E1. 2008-07-10. PMID:18494537. |
a 2-dimensional model of neurotransmitter functions is discussed that describes depression as a mixture of 2 separate components--negative affect and the loss of positive affect--that can be considered in relation to the 3 amine neurotransmitters. |
2008-07-10 |
2023-08-12 |
Not clear |
| Elizabeth Garcia-Perez, John F Wesselin. Augmentation controls the fast rebound from depression at excitatory hippocampal synapses. Journal of neurophysiology. vol 99. issue 4. 2008-06-17. PMID:18199812. |
the residual ca(2+) that persists in presynaptic terminals for several seconds after repetitive use is known to enhance neurotransmitter release under artificial, low probability of release conditions where depression is absent; this is termed augmentation. |
2008-06-17 |
2023-08-12 |
Not clear |
| Yang Luo, Guo-ping H. [Correlative analysis of postpartum depression]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. vol 32. issue 3. 2008-05-05. PMID:17611326. |
to explore the incidence of postpartal depression in the south and north and to comprehensively analyze the changes of sex hormone and neurotransmitter,and their relationship with postpartum depression. |
2008-05-05 |
2023-08-12 |
Not clear |
| Darlene Deecher, Terrance H Andree, Diane Sloan, Lee E Schechte. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology. vol 33. issue 1. 2008-04-01. PMID:18063486. |
the objective of this paper is to review evidence that would support our hypothesis that neurotransmitter systems are affected by changes in hormonal status over the course of a woman's life, leading to increase vulnerability to perimenopausal depression. |
2008-04-01 |
2023-08-12 |
Not clear |
| Tyson B Brust, Francisco S Cayabyab, Brian A MacVica. C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus. Neuropharmacology. vol 53. issue 8. 2008-03-21. PMID:17967469. |
together with functional data indicating that jnk inhibition decreased cpa-induced paired pulse facilitation, these results suggest that jnk activation is necessary for adenosine a1 receptor-mediated synaptic depression occurring at a presynaptic locus the adenosine a1 receptor-jnk signalling pathway may represent a novel mechanism underlying inhibition of neurotransmitter release in the cns. |
2008-03-21 |
2023-08-12 |
rat |
| Charles J Malemud, Andrew H Mille. Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert opinion on therapeutic targets. vol 12. issue 2. 2008-03-13. PMID:18208366. |
peripheral inflammation in ra may influence neurotransmitter metabolism, neuroendocrine function, synaptic plasticity, as well as growth factor production, which can modify neural circuitry and contribute to depression. |
2008-03-13 |
2023-08-12 |
Not clear |
| Siegfried Kasper, Bruce S McEwe. Neurobiological and clinical effects of the antidepressant tianeptine. CNS drugs. vol 22. issue 1. 2008-02-25. PMID:18072812. |
the precise neurobiological processes involved in depression are not clear, but it is recognized that numerous factors are involved, including changes in neurotransmitter systems and brain plasticity. |
2008-02-25 |
2023-08-12 |
Not clear |